Skip to main content

Find Clinical Trials

Home
Conditions
Hepatic Impairment

Clinical trial condition

Hepatic Impairment

Explore clinical trials studying Hepatic Impairment. Study availability and eligibility vary by location and protocol.

237 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Hepatic Impairment trial results

Completed

A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function

NCT00791284

Conditions: Hepatic Impairment, Mental Disorders, Mood Disorders, +2 more
Locations: Not specified

View Trial Details

Completed

Pharmacokinetics, Safety & Tolerability of ZD4054 (Zibotentan) in Subjects With Normal, Mild, Moderate and Severe Hepatic Impairment

NCT00672581

Conditions: Hepatic Impairment
Locations: Research Site Prague, Czechia

View Trial Details

Completed

Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment

NCT00162097

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Johns Hopkins University School Of Medicine Baltimore, Maryland, United States

Uthscsa San Antonio, Texas, United States

Virginia Commonwealth University Health Systems Richmond, Virginia, United States

Local Institution Milan, Italy

View Trial Details

Completed

Hepatic Impairment Study: Pharmacokinetics in Healthy and Hepatically Impaired Subjects

NCT00812305

Conditions: Hepatic Impairment, Neurologic Manifestations, Pain, +2 more
Locations: MTZ Clinical Research Warsaw, Poland

View Trial Details

Completed

TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.

NCT00736905

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

BG9928 in Subjects With Hepatic Impairment

NCT00858156

Conditions: Hepatic Impairment
Locations: Miami, Florida, United States

Orlando, Florida, United States

View Trial Details

Completed

A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment

NCT00768209

Conditions: Hepatic Impairment
Locations: Clinical Pharmacology of Miami Miami, Florida, United States

Orlando Clinical Research Center Orlando, Florida, United States

View Trial Details